Centre Hospitalier Universitaire de Reims, Hôpital Robert Debré

Reims 51100

0 studies enrolling now · 3 studies all time

What they study most

Crohn's Disease, Gastric Cancer, Gastroesophageal Junction Adenocarcinoma, Leukemia, Lymphocytic, Chronic, B-Cell

Studies at this site

• A Study of the Efficacy and Safety of Guselkumab in Participants With Moderately to Severely Active Crohn's Disease — Running, not enrolling
• A Study of the Combination of Ibrutinib Plus Venetoclax Versus Chlorambucil Plus Obinutuzumab for the First-line Treatment of Participants With Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL) — Running, not enrolling
• Bemarituzumab or Placebo Plus Chemotherapy in Gastric Cancers With Fibroblast Growth Factor Receptor 2b (FGFR2b) Overexpression — Completed